Skip Navigation

NIH VideoCasting

CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable file. CIT can also broadcast NIH-only or HHS-only content.

AED Monotherapy Workshop Day 2

Loading video...

Air date: Friday, March 9, 2001, 8:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 93 * This only includes stats from October 2011 and forward.
Category: Conferences
Runtime: 05:44:07
Description: Over the past decade there have been 8 new drugs approved for the treatment of epilepsy. Most of these have been approved initially as adjunctive therapy in highly refractory patients with partial seizures. Only two (felbamate and oxcarbazebine) received an indication for use as monotherapy at the time of approval. Subsequently, a third (lamotrigine) has received an indication for withdrawal to monotherapy in refractory patients.

The use of antiepileptic drugs in monotherapy is supported by data from numerous clinical studies. Refractory patients treated with two or more drugs have better seizure control and fewer side effects when converted to monotherapy. Conversely, when newly diagnosed or refractory patients go from monotherapy to polytherapy, only a small percentage have a substantial reduction in seizures, and most have an increase in side effects.
Debug: Show Debug
NLM Title: AED monotherapy workshop.
Author: National Institutes of Health (U.S.)
Subjects: Anticonvulsants--therapeutic use
Clinical Trials as Topic
Drug Approval
Epilepsy--drug therapy
Publication Types: Congress
Rights: This is a work of the United States Government. No copyright exists on this material. It may be disseminated freely.
Download: To download this event, select one of the available bitrates:
[384k]    How to download a Videocast
NLM Classification: WL 385
NLM ID: 101267408
CIT Live ID: 585
Permanent link: